This opportunity funds Stage 1 preliminary clinical trial applications addressing expanded criteria for endovascular therapy, additional medical therapies, and novel devices within the NIH StrokeNet network. It aims to advance stroke treatment through innovative clinical research in thrombectomy and related interventions.
Eligibility criteria are not specified in the announcement.
